The investigator proposing a single arm prospective pilot trial evaluating the safety and the 1-year erectile recovery outcomes of patients undergoing Nerve Restoring (NR) Robotically assisted laparoscopic radical prostatectomy (RALP). During this study a total of 10 patients who are undergoing robotic prostatectomy will have their surgery performed utilizing a novel technique, NR-RALP, which incorporates a genitofemoral (GFN) nerve graft designed to try to improve the erectile function and recovery of men undergoing standard of care robotic prostatectomy while minimizing additional morbidity of the procedure
Gleason grade ≥8
PSA ≥20
>pT2 on preoperative MRI imaging
Patients must have preoperative erectile function with a baseline IIEF score of ≥17
Patients with previous pelvic surgery
Patients with previous pelvic radiotherapy
Patient with previous focal therapy for prostate cancer
Patients aged < 18 years at diagnosis